SCHEMBL23725396

SCHEMBL23725396

Nc1cc(C(=O)O)ccc1C(=O)Nc1cccc(Br)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX1 P51575 1/20 0.55
HTT P42858 2/20 0.54
ALDH1A1 P00352 2/20 0.54
NR1H4 Q96RI1 1/20 0.54
SORT1 Q99523 1/20 0.52
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
TP53 P04637 1/20 0.50
MAPT P10636 5/20 0.48
MAOB P27338 1/20 0.48
HPSE Q9Y251 1/20 0.48
GRIK1 P39086 1/20 0.47
GRIK2 Q13002 1/20 0.47
NPC1 O15118 1/20 0.47
LMNA P02545 1/20 0.47
ALOX15 P16050 1/20 0.47
RAB9A P51151 1/20 0.47
THRB P10828 2/20 0.47
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10244256 0.84 FADS1 (0.64) P2RX1NR1H4MEN1KMT2AGRIK1
SCHEMBL5666409 0.81 P2RX1 (0.70) P2RX1HTTALDH1A1SORT1MEN1
SCHEMBL8462114 0.81 KMT2A (0.69) P2RX1HTTALDH1A1NR1H4MEN1
SCHEMBL5532340 0.81 HTT (0.64) P2RX1HTTALDH1A1NR1H4MEN1
SCHEMBL22720135 0.80 HSPD1 (0.55) P2RX1HTTALDH1A1SORT1MEN1
SCHEMBL2649328 0.78 GAA (0.73) HTTALDH1A1MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL27656572 0.77 TGM2 (0.68) P2RX1HTTALDH1A1MEN1KMT2A
SCHEMBL7820408 0.77 P2RX1 (0.72) P2RX1HTTALDH1A1SORT1MEN1
SCHEMBL10428749 0.77 ALDH1A1 (0.58) ALDH1A1KMT2A
SCHEMBL5534714 0.76 PRSS12 (0.54) P2RX1ALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 EP disclosed
CN-115413275-A Substituted 1,1 , -biphenyl compounds and methods of use thereof 爱彼特生物制药公司 2022-11-29 CN disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL P2RX1 1936/4885HTT 241/4885ALDH1A1 172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.